VRDN

Conviction 42HealthcareScan · Fri, Jun 26, 2026

VRDN$17.85+2.65%

ResistanceSupportVol 14Insider buy

Vol MA14 1.87M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Viridian Therapeutics, Inc.DEPHARMACEUTICAL PREPARATIONSwww.viridiantherapeutics.com ↗

Price17.85

Change+2.65%

Gap+0.92%

Rel volume2.00×

Avg volume1.8M

Avg $ vol30.14M

SMA 2016.63

SMA 5016.12

SMA 20024.11

Price vs 50+10.70%

Price vs 200-25.97%

MA stackmixed

50/200 cross—

Supertrendup · 15.48

RSI (14)59

MACD hist0.18

MACD crossbull · 6d

Stoch %K / %D83 / 74

ADX (14)18

+DI / −DI28 / 14

RSI divergence—

MACD divergenceBearish

ATR %+4.69%

ADR %4.63%

52w high33.78

52w low13.30

From 52w high-47.16%

Above 52w low+34.21%

New 52w highNo

SqueezeOff

Bollinger width16.09%

%B0.96

Donchian pos83.33%

Donchian high18.32

Donchian low15.50

AVWAP (52w high)20.32

vs AVWAP high-12.15%

AVWAP (52w low)17.10

vs AVWAP low+4.41%

OBV trendFlat

Chaikin MF (20)-0.20

Today vs 20d2.00×

Avg vol (14d)1.87M

Avg vol (20d)1.8M

Avg $ vol (20d)30.14M

Market cap—

RS 3m (vs SPY)-50.46%

RS 6m (vs SPY)-53.67%

RS line new highNo

Trend template3/8

Technical rank37.3

1 week+7.34%

1 month+3.42%

3 months-36.70%

6 months-44.41%

1 year+21.43%

YTD-41.82%

P/E-5.23

P/B2.82

P/S314.14

P/FCF-6.47

EPS-5.31

Div yield—

ROE-53.87%

ROA-43.42%

Debt/Eq0.05

Current15.15

EV/EBITDA-4.95

Gross margin—

Net margin—

Rev growth-12.00%

EPS growth-26.91%

Price target32.42

Target upside86.43%

Analyst ratingBuy

Institutional106.31%

Ent. value1.8B

Revenue2.11M

Net income-104.9M

Gross profit—

Free cash flow-276.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out103.07M

Employees252

ListedWed, Jun 18, 2014

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank37.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance19.10

Support15.58

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VRDN

All disclosures →

No recent disclosed trades by Congress in VRDN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRDN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Fairmount Funds Management LLC Director · Common Stock · 2026-05-11	Buy	1.18M	$20M	2026-05-11	2026-05-13
Fairmount Healthcare Fund II L.P. Director · Common Stock · 2026-05-11	Buy	1.18M	$20M	2026-05-11	2026-05-13
Fairmount Healthcare Fund II GP LLC Director · Common Stock · 2026-05-11	Buy	1.18M	$20M	2026-05-11	2026-05-13

SEC filings

EDGAR filings in VRDN · 1 recent

EDGAR →

8-K8-KWed, Jun 3, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.